US Patent

US11312698 — Fosnetupitant chloride hydrochloride having improved stability

Composition of Matter · Assigned to Helsinn Healthcare SA · Expires 2032-05-23 · 6y remaining

Vulnerability score 12/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects the chemical structure of fosnetupitant chloride hydrochloride with improved stability.

USPTO Abstract

Fosnetupitant chloride hydrochloride having improved stability, characterized by the following chemical structure:

Drugs covered by this patent

fosnetupitant-chloride-hydrochloride (FOSNETUPITANT CHLORIDE HYDROCHLORIDE)

Patent Metadata

Patent number: US11312698
Jurisdiction: US
Classification: Composition of Matter
Expires: 2032-05-23
Drug substance claim: Yes
Drug product claim: Yes
Assignee: Helsinn Healthcare SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.